Bot and colleagues demonstrate shRNA- derived long-term silencing and consequent loss of functionality both in vitro and in vivo. Their work represents a front-line study constructing hematopoietic knock-downs using RNAi.
|Number of pages||1|
|Publication status||Published - Aug 15 2005|
ASJC Scopus subject areas